By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
| Currency | US Dollars |
| Share Price | $ 118.84 |
| Change Today | $ -4.56 |
| % Change | -3.70 % |
| 52 Week High | $124.08 |
| 52 Week Low | $87.75 |
| Volume | 9,065,499 |
| Shares Issued | 1,246.00m |
| Market Cap | $148,075m |
| RiskGrade | 120 |
| Strong Buy | 9 |
| Buy | 12 |
| Neutral | 6 |
| Sell | 1 |
| Strong Sell | 0 |
| Total | 28 |

| Time | Volume / Share Price |
| 15:59 | 231 @ $118.84 |
| 15:59 | 150 @ $118.86 |
| 15:59 | 100 @ $118.82 |
| 15:59 | 100 @ $118.83 |
| 15:59 | 100 @ $118.83 |
You are here: research